Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $0.62 - 0.07 (10.14%)
Today's Open$0.68
Previous Close$0.69
Data as of 12/14/18 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $0.62 with a 52 week high of $4.05 and a 52 week low of $0.64.
Recent News

December 03, 2018

NantHealth® to Present New Research Findings at the San Antonio Breast Cancer Symposium

Topics to include DNA and RNA profiling and next-generation sequencing of tumors SAN ANTONIO--(BUSINESS WIRE)--Dec. 3, 2018-- Significant developments in breast cancer research will be presented by NantHealth (NASDAQ: NH) at the San Antonio Breast Cancer Symposium this week. NantHealth, a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, will discuss the findings of three investigations, w...

Read More >

November 15, 2018

NantHealth Reports 2018 Third-Quarter Financial Results

Total Revenue in Q3 was $22.3 Million SaaS revenue of $15.9 million in Q3, up 5% from $15.2 million in prior year Q3 Enhanced efficiencies continued to drive reduced operating expenses and improved adjusted bottom line results Sequencing and Molecular Analysis, 930 total tests ordered in Q3, including 461 GPS Cancer® and 469 Liquid GPS® Tests...

Read More >

November 07, 2018

NantHealth to Report 2018 Third-Quarter Financial Results and Host Conference Call on Thursday, November 15

--Slight Delay in Reporting Financial Results, Due to Effects of Hurricane Michael-- CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 third quarter on Thursday, November 15, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p....

Read More >

Upcoming Events
There are currently no events scheduled.